Metraipolis › archive › dc_3b3f4d87faa5
Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative report — Europe PMC PMID:41052604
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41052604
- DOI
- 10.1016/j.radonc.2025.111200
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T14:03:16.752Z
- SHA-256 of the archived text
fc27ee9da25c52863177583a534f57f328f2befdb5181ce31cfb39bdcb1a9b93- Stable URL of this page
https://metraipolis.com/documento/dc_3b3f4d87faa5
How to cite
Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative report — Europe PMC PMID:41052604 — Europe PMC (en), https://europepmc.org/article/MED/41052604 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3b3f4d87faa5 (Metraipolis archive dc_3b3f4d87faa5, sha256 fc27ee9da25c52863177583a534f57f328f2befdb5181ce31cfb39bdcb1a9b93)
BibTeX
@misc{dc3b3f4d87faa5,
title = {Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative report — Europe PMC PMID:41052604},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41052604},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3b3f4d87faa5; sha256 fc27ee9da25c52863177583a534f57f328f2befdb5181ce31cfb39bdcb1a9b93},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41052604. Agents can read the archived copy with the MCP tool read_document.